Notice of Interim Results & Investor Presentation
Ondine Biomedical Inc. will release its unaudited interim financial results for the period ending June 30, 2025, on September 26, 2025. A live presentation regarding these Half Year Results will be given by the President and Interim Chief Financial Officer via Investor Meet Company on the same day at 16:30 BST. The company encourages existing and potential shareholders to participate, with questions accepted before and during the event until September 25, 2025, at 09:00 BST. Interested parties can register for free on the Investor Meet Company platform to access the presentation.
Select text to share a quote on X · sign in to keep highlights & notes in your OBI notes
Ondine Biomedical Inc. (AIM: OBI) announces that it will publish its unaudited interim financial results for the period ended 30 June 2025 ("Half Year Results") on 26 September 2025.
- Nicolas Loebel, President and Chief Technology Officer, and Alan Thomas, Interim Chief Financial Officer, of the Company, will provide a live presentation relating to the Half Year Results via Investor Meet Company on 26 September 2025 at 16:30 BST (08:30 Pacific time).
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 25 September 2025, 09:00 BST (01:00 Pacific time), or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet ONDINE BIOMEDICAL INC. via:
About Ondine Biomedical Inc.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.